Sage Journals: Discover world-class research

Abstract

The management of acute deep vein thrombosis (DVT) by medical therapy with anticoagulation has long been supported by evidence-based clinical practice guidelines outlined in the American College of Chest Physicians supplement. Early thrombus removal in patients with iliofemoral DVT has been reported to lead to improved venous valve function, improved quality of life, and decreased incidence of postthrombotic syndrome over anticoagulation alone. The ATTRACT trial will randomize patients to medical management with standard anticoagulation versus catheter-directed thrombolysis in addition to standard anticoagulation after stratification to iliofemoral versus femoropopliteal DVT in order to determine the primary outcome of postthrombotic syndrome over a 24-month follow-up.

Keywords

iliofemoral DVT postthrombotic syndrome catheter-directed thrombolysis

Get full access to this article

View all access options for this article.

References

Kearon C. , Kahn SR , Agnelli G. , Goldhaber SZ , Raskob G. , Comerota AJ Antithrombotic therapy for venous thromboembolic disease: ACCP Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:454S-545S.

Douketis JD , Crowther MA , Foster GA , Ginsberg JS Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med. 2001;110:515-519.

Bjarnason H. , Kruse JR , Asinger DA , et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405-418.

Mewissen MW , Seabrook GR , Meissner MH , Cynamon J. , Labropoulos N. , Haughton SH Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39-49.

Comerota AJ , Kagan SA Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis. Phlebology. 2000;15:149-155.

Comerota AJ , Throm RC , Mathias SD , Haughton S. , Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130-137.

Alguire PC , Mathes BM Chronic venous insufficiency and venous ulceration. J Gen Intern Med. 1997;12:374-383.

Scott TE , LaMorte WW , Gorin DR , Menzoian JO Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg. 1995;22:622-628.

Prandoni P. , Villalta S. , Bagatella P. , et al. The clinical course of deep-vein thrombosis: prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997;82:423-428.

10.

Paolini DJ , Jones LS , Comerota AJ Hyperemic maximal venous outflow unmasks symptomatic lower extremity venous obstruction. J Vasc Surg. 2008;48:749-753.

11.

Lalka SG , Unthank JL , Nixon JC Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension. J Surg Res. 1998;74:59-63.

12.

Saharay M. , Shields DA , Porter JB , Scurr JH , Coleridge Smith PD Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg. 1997;26:265-273.

13.

Schmid-Schonbein G. Molecular basis of venous insufficiency. In: Bergan JJ , ed. The Vein Book. Burlington, MA: Elsevier; 2007:67-79.

The ATTRACT Trial: Rationale for Early Intervention for Iliofemoral DVT

Abstract

Keywords

Get full access to this article

References